B. Siegmund, M. Zeitz
Feb 1, 2003
Citations
1
Influential Citations
28
Citations
Journal
IDrugs : the investigational drugs journal
Abstract
Vertex is collaborating with Aventis Pharma AG (formerly Hoechst Marion Roussel Inc) in the development of pralnacasan, an interleukin (IL)-1b converting enzyme (ICE) inhibitor, for the potential treatment of inflammatory diseases [170247], [188293], [453094].